Body composition assessment of premature infants in the neonatal intensive care unit by Nagel, Emily
Body Composition Assessment of Premature Infants in the Neonatal Intensive Care Unit 
 
A Dissertation 
SUBMITTED TO THE FACULTY OF THE  
UNIVERSITY OF MINNESOTA  
BY 
 
Emily Maria Nagel 
 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 































This work would not have been possible without the support of many people.  
I am grateful to the parents of study participants for allowing their infants to take part in 
my research in the neonatal intensive care unit at Masonic Children’s Hospital.  
Many thanks to my advisor, Dr. Carrie Earthman and my committee of “power women”, 
Dr. Sara Ramel, Dr. Ellen Demerath, and committee chair Dr. Cathy Kotz for lending 
your expertise and guidance and for being fantastic role models and examples of women 
excelling in research. I have learned so much from all of you. A special thank you to my 
faculty adviser, Dr. Carrie Earthman, for supporting my pursuit of pediatric research and 
providing encouragement and guidance along the way.  
Thank you to Dr. Ellen Demerath and Dr. David Vock for creating time to assist with the 
statistical methods for my research.  
I am grateful to the Healthy Foods Healthy Lives Institute and the Gerber Foundation for 
their financial support of this research. 
Thank you to current members of the Earthman lab, Katie Price and Alissa Perteet-
Jackson for your camaraderie and friendship and to former members, Adam Kuchnia 
and Levi Teigen for the many hours of discussion (and continued mentorship), including 
me in your research, and for not getting mad at me for my aggressive manuscript edits. I 
owe a lot of my success thus far to both of you. 
To Laura Gearman and the pediatric dietitians at Masonic Children’s Hospital—thank 
you for allowing me to continue developing my clinical skills in between classes and 
research. 
To my amazing parents-thank you for being my biggest fans and always encouraging 
me to “just do the next thing” and remember to “cross that bridge when I come to it.” You 
are the reason why I chose to study nutrition. 
To Dave, my partner and best friend-a million thanks for moving to the frozen tundra of 
Minnesota with me and for listening to me talk endlessly about my research for the past 













 Premature infants experience growth alterations that place them at risk for 
adverse metabolic and neurodevelopmental outcomes. Monitoring the quality of weight 
gain through body composition assessment in the neonatal intensive care unit (NICU) 
may help clinicians gauge the response to nutritional provision and guide future 
interventions that promote adequate growth and neurodevelopment while reducing the 
risk for obesity and metabolic disease.  
 While length and weight are regularly tracked during an infant’s NICU stay, these 
measurements do not adequately represent total body adiposity shortly after birth. Thus, 
a method of body composition which is non-invasive, portable, and able to be frequently 
utilized in both critically ill and medically stable infants is desirable. Unfortunately, many 
current methods of body composition are invasive, expensive, involve ionizing radiation, 
or are unsuitable for repeated measurement in a medically fragile infant. Thus, this 
dissertation project explores methods to monitor body composition in premature infants 
in the NICU setting with a focus on ultrasound.  
  The first study explored the ability of weight for length indices of the body to 
serve as proxies for adiposity in preterm infants. Indices examined include weight for 
length (W/L), body mass index (BMI), and ponderal index (PI). Each index was 
examined for its ability to predict fat mass (FM), fat-free mass (FFM), and percent body 
fat (%BF). None of the indices adequately reflected adiposity in preterm infants, 
indicating that assessing body composition in preterm infants requires more than weight 
and length measurements, and other methods of bedside assessment should be 
pursued. 
The second study examined the ability of ultrasound to assess body composition 
in premature infants in the NICU setting. Ultrasound images of the biceps, abdomen, 
and quadriceps were obtained for assessment of adipose and muscle thickness and 
were compared with body composition measurements (FFM, FM, %BF) taken using air 
displacement plethysmography (ADP). While ultrasound measurements of biceps and 
quadriceps muscle thickness correlated with total FFM, ultrasound measurements were 
not included in final models for predicting FFM. Biceps, abdomen, and quadriceps 
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adipose thickness correlated with total FM and %BF, but only biceps adipose was 
selected in the final model predicting %BF. The sum of ultrasound adipose thickness 
measures was selected for the final model predicting %BF. However, all models had low 
predictive ability due to low proportion of variance explained (R2) and/or high prediction 
error (root mean square error, RMSE).  
While the study conducted here does not support the use of ultrasound 
measurements of adipose and muscle thickness of the biceps, abdomen, or quadriceps 
alone to predict body composition in preterm infants, exploration of additional sites or 
cross-sectional area may improve predictive ability. Additionally, ultrasound 
measurements may have some value as a prognostic tool for other clinical outcomes, 
such as neurodevelopment or readiness for NICU discharge. Regardless, this work 
highlights the need for clinical body composition methods appropriate for premature 
infants to help monitor for disease risk and assist in the refinement of current nutrition 
practices in the NICU.  
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In 2017, approximately 10% of babies born in the Unites States were born 
prematurely, and in 2016, 17% of infant deaths were due to prematurity and low 
birthweight.1 Prematurity places infants at risk for a myriad of growth, metabolic, and 
neurodevelopmental problems. This may be due, in part, to growth alternations that 
premature infants exhibit, including increased adiposity, decreased fat-free mass (FFM) 
gains, and decreased linear growth for the first 2 years of life in comparison to term 
infants. Weight and length are currently used to evaluate growth and adequacy of 
nutritional provision in the neonatal intensive care unit (NICU), but growing evidence 
suggests that monitoring weight quality is valuable in prevention of adverse metabolic 
and neurodevelopmental outcomes. Weight quality can be monitored by assessing body 
composition or gains in the amount of FFM and fat mass (FM). Unfortunately, very few 
body composition methods are easily used in the NICU setting.  
The goal of nutritional provision in the NICU is to promote growth similar to that 
of term infants.2 However, aggressive nutrition may promote increased gains in FM, 
placing infants at risk for metabolic consequences. Individualized nutritional 
recommendations or the benefits of “early aggressive nutrition” are debated amongst 
clinicians, and it is known that composition of diet can affect body composition in 
premature infants.  
 This dissertation explores the state of body composition analysis in premature 
infants in the NICU, beginning with a literature review of the available clinical body 
composition methods for premature infants in Chapter 2 and continuing with an 
assessment of the ability of weight for length indices to serve as proxies for body 
composition from 30-63 weeks corrected age in Chapter 3. Chapter 4 contains results 
from a study examining the use of ultrasound to assess body composition in the NICU. 
3 
 
 In Chapter 5, conclusions from this work and future directions are presented along with 
preliminary data from continuing studies.  
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CHAPTER 2: LITERATURE REVIEW – CLINICAL APPLICATION OF BODY 












* This chapter has been submitted and is under review for publication at the Journal of 




 Currently, body composition assessment is not part of the routine clinical 
evaluation of premature infants, a population at risk for obesity and metabolic disease. 
Instead, measures of weight and length are used to assess growth in the neonatal 
intensive care unit but are known to be poor predictors of adiposity shortly after birth.  
Monitoring whole body composition (total body fat mass and fat-free mass) in preterm 
infants is essential for optimizing nutrition and promoting growth and neurodevelopment 
while preventing adverse metabolic outcomes. Therefore, a method which allows 
clinicians to track whole body composition during hospitalization is desirable. While body 
composition methods such as magnetic resonance imaging, stable isotope dilution, and 
dual energy x-ray absorptiometry have been examined in infants, they are invasive, 
expensive, involve exposure to radiation, and/or are unsuitable for repeated 
measurements in a medically fragile population. Several body composition methods with 
potential for clinical use at the bedside have been explored in premature infants, 
including air displacement plethysmography, bioimpedance, skinfold measurements, and 
ultrasound. In this review, we examine each method and evaluate feasibility for 
incorporation into clinical care. While these methods show promise for use in premature 
infants, further research is needed before they can be recommended for routine body 
composition measurement in the clinical setting.   
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INTRODUCTION 
Altered growth in premature infants 
Premature infants exhibit growth irregularities that may place them at increased risk for 
obesity and metabolic disease such as decreased fat-free mass (FFM) gains during 
infancy, increased overall adiposity compared to full term infants at term corrected age, 
and decreased linear growth for the first two years of life.3–5 They also undergo an initial 
period of significant growth restriction followed by a period of “catch-up growth” or 
accelerated weight gain, resulting in a greater proportion of fat mass (FM) to FFM.3,5–7 
These growth abnormalities are concerning due to correlation with adverse metabolic 
and neurodevelopmental outcomes later in life.8,9 Currently, clinicians use 
anthropometric measurements such as weight and length to track growth and the 
adequacy of nutritional support, but these measurements do not adequately represent 
FM in premature infants, who have greater adiposity than their term counterparts.3,10,11 
Thus, monitoring both quantity and quality of weight gain via body composition (BC) 
assessment may help clinicians to better understand and prevent adverse long term 
outcomes while simultaneously optimizing growth and neurodevelopment.12 
The case for whole body composition 
Clinicians are interested in whole BC assessment to monitor growth response to 
nutritional intake. A difference in prescribed and actual nutritional intake can negatively 
impact growth.5,13–16Although recommended goals for nutrition exist,2,16 actual intake in 
the neonatal intensive care unit (NICU) varies according to mode of nutritional delivery 
(enteral versus parenteral) and use of human milk or infant formula. Monitoring whole 
BC may allow for comparison of macronutrient and micronutrient provision to optimize 
nutrition for preterm infants.17–19 Furthermore, tracking BC may help to better define the 
relationship between early nutrition, nutrient accretion, and growth.5  
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 Monitoring whole BC may also assist in assessing metabolic and 
neurodevelopmental risk. Multiple studies have linked early catch-up growth to later 
adverse metabolic outcomes such as type 2 diabetes, obesity, and cardiovascular 
disease.6,20–23 Previously, we found that higher gains in FM during a premature infant’s 
hospitalization are positively associated with blood pressure at 4 years of age.9 
Additionally, we discovered that FFM is a better predictor of neurodevelopmental 
outcomes than weight, and higher rates of weight gain and FFM in the NICU are 
associated with improved cognition and faster speed of processing in infancy and at 4 
years of age.8,9 While early catch-up growth in length, FFM, and weight during the first 
several months of life has been shown to improve neurodevelopmental outcomes of 
premature infants in many studies, gains in FM have not shown the same benefit.6,8,22,24  
Evaluation of body composition methods for premature infants 
Validation of a new BC method typically occurs by comparison with a reference method, 
an established technique that produces accurate and reliable estimations of BC. 
Because cadaver analysis is the only way to directly measure BC, every other method 
relies on assumptions and is subject to error.25,26 The four-component model of BC, 
which divides body mass into FM and FFM components of total body water (TBW), 
bone, and protein is considered the most valid reference model because it includes 
independently measured components that are estimated by simpler models.27,28 The 
four-component model is only feasible in the research setting because it requires 
multiple tests and infant cooperation.29 Consequently, evaluation of newer infant BC 
methods often involves comparison with two- or three-component models that have 
been validated against three- or four-component models. The two-component model of 
BC divides the body into FM and FFM and assumes a constant density of FM (0.9007 
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g/mL) and specific age and sex-specific densities of FFM.30 The three-component model 
divides the body into FM and further divides FFM into TBW and dry FFM.31–33  
Challenges to assessing body composition in the NICU 
Assessment of BC in premature infants is difficult because of the known variability in 
FFM composition during growth.34,35 An infant’s TBW decreases while bone mineral 
content increases with increasing postmenstrual age. Compounded with varying fluid 
status from the intravenous provision of fluids while in the NICU, two-compartment 
models that do not directly measure TBW may be inaccurate in critically ill infants. 
Fomon and Butte developed age and sex-specific normative values for TBW and other 
FFM components which may improve the predictive ability of BC methods that rely on 
this data, but these values were derived from term infants.34–36 Similarly, methods that 
rely upon prediction equations to estimate an infant’s thoracic volume are based upon 
reference data from healthy term infants and may not be accurate for preterm infants 
with lung disease.37 Conducting BC assessment in the NICU setting is also challenging 
due to varying medical stability of infants and the need to coordinate measurements 
around nursing care. 
 While magnetic resonance imaging (MRI),29 isotope dilution techniques, 
quantitative MRI, and dual energy x-ray absorptiometry (DXA)29,38–40 have been studied 
in premature infants, these techniques are not suitable for repeated clinical use because 
they involve exposure to ionizing radiation, are expensive, require medical stability, 
and/or are not feasible outside the research setting. These methods have been 
extensively reviewed elsewhere12,29,41 and will not be discussed in our review. The BC 
methods of air displacement plethysmography, bioimpedance, skinfold measurements, 
and ultrasound show promise for repeated clinical use in premature infants. Here, we 
examine each method and its potential for clinical application.  
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Air displacement plethysmography (ADP)  
Only one device, the Pea Pod (Cosmed, Inc., California), is currently available to 
conduct ADP measurements in preterm infants. The Pea Pod determines percent body 
fat (%BF) through body measurements, gas laws, and Fomon’s34 or Butte’s35 age and 
sex specific densities for FFM as described elsewhere.42–44 ADP estimates of BC rely on 
the Pea Pod’s algorithms to account for hydration status in infancy37,45 and estimation of 
functional residual capacity estimates to account for thoracic volume. The validity of 
measurements also relies upon accuracy of length measurements.  
ADP exhibits excellent accuracy when evaluated against direct analysis of bovine 
phantoms46 and superior reliability over repeated measurements43 and has been 
validated against the four-compartment model in term infants.47 Two studies to assess 
accuracy and precision have been conducted in premature infants (Table 1), but the 
effects of covariates such as weight, length, and sex on regression models were not 
examined in either study. Forsum showed moderate accuracy in %BF using ADP 
compared to a three-component method.37,45 No bias was detected. However, ADP 
overestimated low FFM densities and underestimated high FFM densities.45 The other 
study by Roggero compared BC via ADP to that obtained via stable isotope dilution 
studies and found good reliability, precision, and accuracy for %BF measured via ADP 
and H218O dilution. No bias was detected as %BF increased.19  
 Whether ADP can provide useful information in the acute care setting is partially 
dependent upon its ability to detect clinically relevant changes through longitudinal 
measurements of BC. In our previous work, we found that ADP is sensitive enough to 
detect a 30-45 gram change in FFM (~3% change) in measurements taken one week 
apart.8 ADP can also detect differences in %BF of premature infants over a three to four 
week period.48  
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ADP is attractive for use in the clinical setting because it is non-invasive, reliable, 
and relatively easy for clinicians to use. Measurements of ADP are unaffected by crying 
and moderate movement, making it an appropriate tool for use in infants.29,43,47 Another 
advantage of this method is the potential for use of ADP-based BC reference charts to 
monitor growth.49,50 Tracking premature infants on these charts while monitoring clinical 
outcomes may help to determine if current nutritional and growth standards are 
appropriate. 
The cost of the Pea Pod may preclude routine use in the NICU, and it is best 
suited for healthy infants with clinically stable respiratory status, weight between 1 and 
10 kg, and independence from a central line.44 These criteria prevent use of ADP in 
infants who are critically ill, such as premature neonates on ventilators and those 
receiving parenteral nutrition.  
Bioelectrical impedance analysis (BIA)  
BIA measures BC indirectly through the resistive properties of an electrical current in the 
body with the assumption that lean tissue produces low resistance because of its high 
fluid content, while adipose tissue and bone yield a greater level of resistance as a result 
of low fluid content.51,52 Bioimpedance data can be collected using single-frequency 
(SF), multi-frequency (MF), or spectroscopy devices (BIS).53 From bioimpedance data, 
TBW, extracellular and intracellular fluid (ECF, ICF), FM, FFM, and other lean tissue 
compartments can be estimated using mathematical modeling and prediction equations, 
depending on the approach.51 
SF-BIA and MF-BIA rely on assumptions of body shape, uniform conduction of 
the electric current, and use of population-specific equations that are dependent on 
factors such as age, gender, and ethnicity, in order to generate BC or volume 
estimates.53,54 Use of SF-BIA and MF-BIA, which rely on stable hydration status, is 
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challenging in the neonatal population.51 TBW relative to total body mass changes 
throughout infancy, beginning at around 80.6% at birth and decreasing to 78.8% 
(females) and 79% (males) at one year of age, which has implications for the 
measurement of specific tissue, specifically FFM.34 TBW may also depend on weight for 
gestational age, with small for gestational age infants having a greater body water 
content than appropriate for gestational age infants.55 Therefore, the hydration constants 
for FFM used to estimate TBW in conjunction with SF- and MF-BIA equations may not 
be appropriate for use in a growing infant.  
BIS devices, which measure impedance over a wide range of frequencies, are 
more promising for use because they do not rely on population-specific prediction 
equations.56 However, the use of curvilinear modeling and mixture theory-based 
algorithms to determine TBW by spectroscopy requires inclusion of shape and density 
constants and resistivity coefficients, which represent the resistivity of extra- and 
intracellular fluid compartments to an electric current.56,57 As a result of substantial 
variation in resistivity among infants, preterm infants require unique coefficients for 
accurate assessment of TBW, but they may only be suitable for population level 
estimates of TBW.56,58,59 Infant movement and proximity of measurements to feeding 
times have also been shown to impact spectroscopy data, specifically extracellular 
resistance measurements.60  
Multiple studies have concluded that SF-BIA data minimally improves prediction 
equations for whole BC beyond weight, length, and sex and that SF-BIA data is not more 
advantageous than weight for determination of FFM in preterm and term infants.59,61 
Nevertheless, additional research into bioimpedance approaches for BC assessment is 
warranted because of advantages such as suitability for non-invasive serial 
measurements. BIA may be used in critically ill infants despite requiring central lines, 
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respiratory support, and continuous monitoring of vitals.62 However, if infants have not 
achieved fluid balance, SF- and MF-BIA estimates of BC may be inaccurate. BIS 
devices may be more appropriate for use in critically ill preterm infants because they 
employ spectral data modeling to determine ECF and ICF and thus, are not dependent 
on the assumption of fluid balance. However, several constants used in standard BIS 
algorithms are based on adult data and may result in errors in whole BC estimates when 
applied to infants. 
Skinfold Measurements  
Measurements of skinfold thickness (SFT) have been proposed to estimate BC in infants 
(Table 2.1). Multiple measurements taken at various body sites using calipers are then 
associated with whole body FM using prediction equations.63 While these measurements 
are inexpensive, noninvasive, and do not involve exposure to radiation, they may not 
reflect whole body fat in older infants because they assess only subcutaneous adipose 
tissue.29,64 Furthermore, the use of calipers is controversial in medically fragile preterm 
infants, and repeated, accurate measurements may be difficult to obtain because of an 
infant’s small body size and sensitive skin.65 SFT measurements can be influenced by 
fluid status65, type of caliper used,66,67 and amount of time the caliper is applied to the 
skin.68,69  
A validated prediction equation is needed for clinicians to use SFT to determine 
BC. Several have been proposed, but most are derived from models developed in other 
clinical populations and may not be appropriate for use in premature infants.63,70,71 Many 
existing prediction equations also require SFT measurements at multiple sites, which 
may be difficult to obtain in preterm infants. Of note, SFT measurements likely have 
lower intra- and inter-rater reliability than the other methods reviewed here, unless 
conducted by a single trained individual.66 
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A well-known model developed in preterm and term infants by Dauncey includes 
subscapular and triceps skinfold measurements and nine body measurements and has 
good agreement with published data from cadaver analysis.69 Although not validated in 
preterm infants, some consider it the best method for accurate determination of BC in 
this population despite its complexity.65  
Other attempts to develop and validate prediction equations using SFT have 
been met with mixed success,64,72,73 likely due to the variety in model development and 
validation populations and the BC methods against which SFT measurements are 
compared. While some equations demonstrate good correlation with whole BC 
measured using ADP or DXA,63 others have yielded insufficient correlation for 
calculation of individual BC and unacceptable levels of systematic error. 
Four prediction equations for estimating whole body FM in term infants using 
SFT were recently developed by Deierlein, Catalano, Lingwood, and Aris.59,74–76 While all 
equations include covariates such as weight, length, and gender, it is unknown whether 
the covariates alone can predict body composition. When compared to ADP-measured 
whole body FM obtained at birth, all equations except for the Catalano model yield 
significantly different FM. Bias was noted for the Catalano and Lingwood equations, 
indicating that they overestimated FM at lower FM values and underestimated FM at 
greater FM values. At 3 months of age, none of the equations accurately predict whole 
body FM in comparison to ADP-derived measurements. Bias was noted for all 
equations, with the Deierlein equation overestimating FM at all values and the other 
three equations overestimating FM at lower FM values and underestimating FM at 
higher FM values.77  
While more research is needed to develop and validate prediction equations for 
use of SFT to assess BC in premature infants, this method may be most appropriate for 
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the global health care setting because of low cost and accessibility. Measurements may 
be affected by factors such as race and sex, making it important to develop and validate 
population-specific equations.78,79 
Ultrasound 
Ultrasound is a developing method for assessment of whole BC in infants and employs 
high-frequency sound waves to produce an image of the tissue of interest. Images are 
analyzed for either adipose tissue and muscle thickness (or cross-sectional area), which 
is then correlated with whole body FM or FFM generated by established BC methods.80–
82 Ultrasound is not routinely utilized for assessing BC in any clinical population, but 
several studies have shown a correlation between adipose and muscle measurements 
obtained using ultrasound and established BC methods in adults and adolescents.83–88 A 
few of these studies have also generated prediction equations for whole body FM or 
FFM using ultrasound measurements.89–92  
Ultrasound assessment of BC has been minimally explored in infants. Only 
cross-sectional area has been correlated with whole BC; the cross-sectional area of calf 
adipose tissue correlates with whole body FM (r = 0.67) measured via DXA in premature 
infants.93 However, ultrasound has yet to be validated against reference methods 
appropriate for premature infants. 
Ultrasound, a non-invasive tool that involves no ionizing radiation, is readily 
available in the clinical setting and can be quickly performed at the bedside in critically ill 
infants. Ultrasound has good reliability in adult populations94 but appears to have 
variable reliability in premature infants, although data are limited.95 The pressure at 
which the ultrasound transducer is applied affects the measurement of tissues and 
therefore, the precision of measurements.82,96 Care must be taken to use consistent 
compression during measurement, though no universal method has been developed for 
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this purpose. The consistent identification of measurement sites may be difficult in a 
rapidly growing infant, and inconsistencies may impair comparison of longitudinal 
measurements. Refinement of ultrasound techniques, including development of a 
standardized protocol for use in premature infants, would greatly assist in addressing 
these issues. If able to accurately estimate FM, ultrasound would represent the only 
clinical BC assessment method with the potential to assess a patient from birth through 
adulthood.  
DISCUSSION 
 The inclusion of BC assessment in clinical evaluation has the potential to provide a 
better understanding of growth in premature infants. All methods discussed (Table 2.2) 
show promise for clinical use and should be further explored. However, none are four-
component models, and the limitations of each must be considered when choosing the 
best method for use in the clinical setting. ADP, which has been validated against the 
four-component model in term infants and compared with the three-component model in 
preterm infants, is currently the most accurate and reliable method for assessing body 
composition in preterm infants. ADP, however, requires a costly device, and infants are 
not eligible for measurement unless they are medically stable. BIA and SFT have been 
compared with the two-component model but need refinement for routine use in the 
clinical setting. Whole BC via ultrasound has not been validated against two- or three-
component models, but we felt it warranted discussion due to its potential use in critically 
ill infants.  
  Moving forward, the first step in identifying a clinically relevant, bedside BC 
modality in preterm infants is the evaluation of one-time measurements. This must be 
followed by an assessment of the method’s ability to detect longitudinal changes in 
whole BC, which is important to provide meaningful information for routine clinical 
16 
monitoring. Once a bedside modality is proven effective for longitudinal measures, 
regular assessment of BC in response to nutritional provision can be conducted. Routine 
monitoring may facilitate the development of new nutritional recommendations for 
healthy and critically ill premature infants that promote gains in FFM and reduce 
adiposity. Achieving such BC changes could ultimately decrease the risk for childhood 









































Ellis47: 49 term 
infants 
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Mean bias 0.6 ± 3.7% 
(non-significant); LOA:-
6.8 and 8.1% 
%BF via ADP 
slightly but not 
significantly 
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LOA: -6.8 and 4.8% 
%BF via ADP 
slightly but not 
significantly 
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Birth: Mean bias 1.5% 
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%FFM, but BIA 
has limited use 
in predicting 
FFM in first 
weeks of life 
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SFT DXA 
*Dung61: 51 male, 
67 female 
preterm neonates 
Not done %FFM 
Males: mean bias 0.10%; 
95% CI: -1.2 and 1.42% 
 
Females: mean bias -
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*Aris76: 262 term 
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ICC: 0.83 to 
0.96; TEM: 0.23 
to 0.34 
 
FM (kg)  
Birth: 
Deierlein: Mean bias 
0.114 kg; LOA: -0.010 
and 0.328 kg 
 
Catalano: Mean bias -
0.012 kg; LOA: -0.240 
and 0.215 kg 
 
Lingwood: Mean bias  
-0.045 kg; LOA: -0.272 
and 0.183 kg  
 
Aris: Mean bias -0.034 
kg; LOA: -0.245 and 
0.176 kg  
 
3 months:  
Deierlein: Mean bias 
3.325 kg; LOA: 1.789 
and -4.862 kg  
 
Catalano: Mean bias -
0.271 kg; LOA: -0.871 
and 0.328 kg  
 
Lingwood: Mean bias  
-0.286 kg; LOA: -0.871 
and 0.299 kg  
 
Aris: Mean bias -0.230 
kg;  
LOA: -0.824 and 0.363 
kg  
Poor precision 
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R2 =0.49 (preterm); 0.41 
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FM (kg) 
Sum of triceps, 
subscapular, thigh SFT: 
R2 = 0.81; p<0.0001; 




including sum of 
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81% of variance 
in FM.  
Lingwood59: 72 
term infants at 
birth; 65 term 
infants at 6 weeks 
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SFT yielded large mean 
bias at birth and 6 weeks  
 
Underestimation of %BF 
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SFT did not 
improve 
prediction of 




















length, flank SFT): R2 = 
0.84; p=0.0001 
 







between FM via 
Catalano model 
and TOBEC in 
infants at birth. 
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Sum of triceps, biceps, 
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Mean bias: 
≤500 g: 75 g 
500-1000 g: 170 g 
1001-2000: 300 g 
>2000 g: 370 g 
 
R2 = 0.95; p<0.001 
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r=0.82 
 







may be useful in 
obtaining 
information 
about FM in 
premature 
infants. 
Table 1. Summary of studies on the precision and accuracy of body composition methods. 
%BF, percent body fat, %CV, percent coefficient of variation; 4C, four-component model; 3C, 
three-component model; ADP, air displacement plethysmography; BIA-SF, single-frequency 
bioimpedance analysis; BIS, bioimpedance spectroscopy; CI, 95% confidence interval; CL, 
95% confidence limits; DXA, dual energy x-ray absorptiometry; FM, fat mass; ICC, intraclass 
correlation coefficient; LOA, Bland Altman 95% Limits of Agreement; MAC, midarm 
circumference; SFT, skin fold thickness, TEM, technical error of measurement  
*validation study 
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Table 2.2: Evaluation of Body Composition Methods for Bedside Assessment of Preterm Infants 
 
Method Validated in 
Preterm Infants? 
Advantages Disadvantages Suggested Use 
ADP Yes • Non-invasive 
• No radiation 
• Unaffected by movement/crying 
• 1-10 kg weight limit 
• Infants must be on room air 
• No central line 
• Expensive 
• Not for critically ill infants 
 
• Medically stable infants 
• NICU or outpatient clinic 
settings 
BIA No • Non-invasive 
• No radiation 
• Can be performed at bedside 
• Appropriate for critically ill infants 
(BIS) 
• Requires population specific 
information 
• May require stable hydration 
status 
• Sensitive to infant movement 
• May be affected by feeds 
 
• Medically stable infants with 
balanced hydration status 
(BIS) 
• NICU or outpatient clinic 
settings 
 
SFT No • Minimally invasive 
• No radiation 
• Can be performed at bedside 
• Inexpensive 
• Appropriate for critically ill infants 
• No consensus protocol 
• Influenced by fluid status, 
caliper type, length of 
measurement 
• Low reliability with multiple 
observers 
 
• Medically stable infants 
• Outpatient clinic setting 
• Global healthcare setting 
US No • Non-invasive 
• No radiation 
• Can be performed at bedside 
• Appropriate for critically ill infants 
• Available at most hospitals  
• No validated protocol 
• Affected by tissue 
compression 
• Consistent measurements 
may be difficult 
 
• Critically ill or medically stable 
infants 
• NICU or outpatient clinic 
settings  
• Potential for use in the global 
healthcare setting 
Table 2. Advantages and disadvantages of body composition methods used to assess preterm infants. ADP, air displacement 




CHAPTER 3: ANTHROPOMETRIC MEASURES DO NOT ADEQUATELY REFLECT 





















CHAPTER SYNOPSIS  
Background: Growth in premature infants is currently assessed through measures of 
weight and length, but weight/length indices such as body mass index are known to be 
poor surrogates for adiposity shortly after birth. Whether these indices can predict body 
composition later in infancy is unknown. Should they prove to be adequate surrogates 
for body composition, weight/length indices could be used to assess weight quality in 
premature infants, potentially improving growth and guiding nutritional provision. 
Objective: To determine the ability of weight/length indices to predict adiposity in 
premature infants from 28-63 weeks corrected gestational age.  
Methods: Data from 260 preterm infants and 95 term infants was compiled from three 
studies conducted at the University of Minnesota’s Neonatal Intensive Care Unit from 
2010-2019. Whole body fat mass and fat-free mass and percent body fat were obtained 
using air displacement plethysmography beginning when infants were medically stable 
and continuing through 63 weeks corrected gestational age. Weight, length, 
weight/length, body mass index, and ponderal index were assessed for their ability to 
predict fat mass, fat-free mass, and percent body fat in four age groups. Fat mass and 
fat-free mass index were examined as secondary outcomes. The predictive ability of 
weight/length indices was also compared in preterm infants < 32 and > 32 to 36 + 6 
weeks gestational age at birth. Finally, predictive ability of indices was compared in 
preterm infants at term-equivalent age and term infants. The best proxy for whole body 
composition was determined by selection of the linear regression model with the highest 
variance explained (R2) and lowest root mean square error (RMSE). 
Results: BMI was the best predictor of percent body fat for the first three age groups but 
resulted in poorly fitting models with low variance explained (R2 = 0.34-0.35) and high 
prediction errors (RMSE = 3.21-4.01). Weight for length was the best predictor of %BF 
for the oldest age group, but also exhibited low variance explained (R2 = 0.13) and high 
prediction error (RMSE = 4.41). Weight was the strongest predictor of fat-free mass 
across all age groups (R2 = 0.81-0.94; RMSE = 0.06-0.30). 
Conclusions: None of the weight/length indices examined accurately represented 
adiposity in preterm infants. Weight/length indices cannot be used to assess adiposity in 




Clinicians are interested in the quality of weight premature infants gain in the neonatal 
intensive care unit (NICU) because of the relationship between body composition and 
metabolic and neurodevelopmental outcomes. Weight quality can be assessed by 
monitoring changes in fat mass (FM) and fat-free mass (FFM) as infants grow. In 
comparison with term infants, premature infants exhibit decreased FFM gains, 
decreased linear growth, and increased relative adiposity at term corrected age.3–6 They 
also experience a period of rapid growth or “catch-up growth”, which may increase their 
risk for later insulin resistance, obesity, and cardiovascular disease.22,101–103 While 
greater FM gains after NICU discharge until four months of age are associated with 
increased blood pressure at four years of age,9 gains in FFM (but not FM) are 
associated with improved neurodevelopmental outcomes.24,104  
The American Academy of Pediatrics recommends nutritional goals aimed at 
helping preterm infants achieve growth equal to that of term infants of the same 
corrected age.105 Better nutrition support is associated with improved growth and 
neurodevelopmental outcomes in multiple studies. 8,106–109 However, assessing an 
infant’s response to nutrition support is currently limited by the available growth metrics 
of weight and length. Despite the known relationship between early body composition 
and later outcomes, body composition is not routinely measured in the NICU because of 
the limitations of currently available tools. Many methods are expensive, invasive, or 
unsuitable for repeated measurements in a medically fragile population. The use of 
simple weight for length (W/L) indices to assess body composition would provide a fast 
and non-invasive way to assess a premature infant’s quality of weight gain in response 
to nutritional provision in the NICU, regardless of medical stability. Due to growth 
irregularities, assessing proportionality of growth in preterm infants is also desirable. 110 
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Ponderal index (PI) and body mass index (BMI) have been proposed as proxies for 
infant adiposity or percent body fat (%BF). In healthy term infants, neither PI or BMI can 
accurately predict %BF.111 In preterm infants, BMI is a better predictor of proportionality 
than PI, and gender-specific BMI curves for preterm infants have been created and 
validated.110,112  
Previously, we examined W/L indices (weight, length, W/L, BMI, PI) of preterm 
infants shortly after birth (within 72 hours) and found that none of the indices examined 
accurately reflected %BF.10 Whether BMI is predictive of adiposity in preterm infants 
later in infancy is unknown. Thus, in this study, we aimed to determine if W/L indices are 
predictive of FFM, FM, or %BF in preterm infants at various timepoints after the first 
week of life, including 28 to 33 weeks corrected gestational age (CGA), 34 to 36 weeks 
CGA, 37 to 42 weeks CGA, and 50 to 63 weeks CGA. 
METHODS 
Data from 355 infants (preterm = 260 infants; term = 95 infants) recruited from the 
University of Minnesota’s Neonatal Intensive Care Unit between 2010-2019 were 
included in this study. Study inclusion criteria included birth between < 32 to 36 + 6 
weeks gestational age (GA), medical and respiratory stability, and independence from 
central lines at time of measurement. Infants with medical conditions (other than 
prematurity) known to affect growth or adiposity were excluded. All measurements were 
taken ≥ 7 days after birth. 
The Pea Pod (Cosmed, Ltd, Concord, California) was used to evaluate body 
composition by air displacement plethysmography (ADP). The Pea Pod’s operating 
procedures have been described elsewhere.43–46 Briefly, a recumbent length board was 
used to measure each infant’s length to the nearest 0.1 cm. Naked weight to the nearest 
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0.0001 kg was obtained using the Pea Pod’s electronic scale followed by an 
approximately 2-minute body volume measurement in the device’s test chamber. The 
body volume measurement, the known density of fat (0.9007 g/mL), and Fomon’s34 or 
Butte’s35 age and sex specific densities for FFM were then used by the Pea Pod’s 
software to calculate %BF. Weight and length z-scores were calculated using the 
Fenton113 growth charts for preterm infants until 50 weeks CGA, while the World Health 
Organization (WHO) growth charts114 were used for preterm infants ≥ 50 weeks CGA 
and for term infants. All measurements were taken by a consistent study team.  
Statistical Analysis 
For preterm infants, anthropometric and body composition measurements were divided 
into four groups based upon the CGA at which they were obtained: ≤ 33 weeks 
corrected CGA (group one), 34 to 36 weeks CGA (group two), 37 to 42 weeks CGA 
(group 3), and 43 to 63 weeks CGA (group four). Since measurements were taken 
longitudinally during an infant’s NICU stay, some infants had measurements in all CGA 
groups and others had multiple measurements within the same CGA group. If multiple 
measurements from an infant were present in the same CGA group, the measurement 
taken closest to the midpoint of the CGA group was selected. 
The relationship between W/L indices and primary outcomes of FFM, FM, and 
%BF and secondary outcomes of FFM/L2 (FFMI) and FM/L2 (FMI) were examined by 
CGA group using linear regression analysis. Weight, length, W/L, BMI (W/L2), and PI 
(W/L3) were assessed as predictors. To ascertain whether gestational age at birth 
affected the prediction of our outcomes, we further compared the predictive ability of W/L 
indices in preterm infants born < 32 weeks and ≥ 32 to 36 + 6 weeks gestational age. 
Finally, to examine differences in predictive ability between preterm infants at term-
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equivalent age and term infants, we compared W/L indices in the last two CGA groups 
combined. Random effects models were used to account for the correlation between 
repeated measurements. The best proxy for whole body composition was the linear 
regression model with the highest variance explained (R2) and lowest root mean square 
error (RMSE). To account for the number of models examined, p-values are two sided 
with p < .00025 considered statistically significant. SAS 9.4 (SAS Institute, Cary, North 
Carolina) was used to perform statistical analyses.  
RESULTS 
Characteristics of infant participants are described by CGA group in Table 3.1.  Infants in 
the youngest CGA group had mean GA of 29.25 weeks, were 41% male, and 16% 
white, while preterm infants in the oldest CGA group had mean GA of 28.81 weeks, were 
53% male, and 6% white. Infants in the youngest CGA group had the lowest mean %BF 
(8%), while preterm infants in the oldest CGA group had the highest mean %BF (22.9%).  
 Table 3.2 shows the relationship between the predictors of weight, length, W/L, 
BMI, PI and the outcomes of FFM, FM, and %BF by CGA group. All W/L indices in each 
of the four CGA groups were significantly correlated with FM except for PI in CGA group 
four. BMI was most strongly correlated with FM in CGA groups one and two, while W/L 
was most strongly correlated with FM in CGA groups three and four. Weight, W/L, and 
BMI were significantly correlated with %BF in all CGA groups, but length exhibited 
significant correlation only for CGA group one, and PI was significantly correlated only in 
CGA groups one, two, and three. BMI was most strongly correlated with %BF (r = 0.58) 
in groups one through three, while W/L was most strongly correlated with %BF in group 
four (r = 0.43). Weight, length, W/L, and BMI were significantly correlated with FFM 
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across all CGA groups, but PI was only significantly correlated with FM in group one. 
Weight was most strongly correlated with FFM across all CGA groups.  
 The R2 and RMSE of models examined in linear regression analyses are shown 
according to CGA group in Table 3.3. BMI was the best predictor of %BF for CGA 
groups one, two, and three (Figure 3.1, 3.2, and 3.3), while W/L was the best predictor 
of %BF for the oldest CGA group (Figure 3.4). Large prediction errors were observed for 
W/L indices and %BF across all CGA groups. BMI was the best predictor of FM for the 
first two CGA groups, while W/L was the best predictor for CGA group three, and weight 
was the best predictor for the oldest CGA group. Weight was the best predictor of FFM 
across all four CGA groups.  
For our secondary analyses, BMI was a moderate predictor of FMI for the first 
three CGA groups, while all W/L indices were weak predictors of FMI for the oldest CGA 
group (Table 3.4). BMI was a strong predictor of FFMI for all CGA groups but generally 
decreased as preterm infants grew older.  
 The ability of W/L indices to predict %BF in preterm infants < 32 weeks GA at 
birth and ≥ 32-36 + 6 weeks GA at birth is shown in Table 3.5. All W/L indices were 
significant predictors of %BF (p <.0001). For all W/L indices except for PI, GA at birth (< 
32 weeks or ≥ 32 weeks) was a significant predictor of %BF. A significant interaction 
between GA and W/L indices was present for all indices except for PI. Sex was not a 
significant predictor of %BF. 
 The relationship between W/L indices and %BF for preterm infants at term-
equivalent age versus term infants is shown in Table 3.6. All W/L indices were significant 
predictors of %BF. For all W/L indices, term status was a significant predictor of %BF, 
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while sex was not a significant predictor. A significant interaction between term status 
and W/L indices was present for all models.  
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Table 3.1: Infant descriptive characteristics and body composition by corrected age at measurement 
Variablea CGA Group 1 
(n=74) 
 CGA Group 2 
(n=175) 
 CGA Group 3 
 
 CGA Group 4 
 
Characteristics 








GA at birth (weeks) 29.25 ± 1.78  30.09 ± 2.79  28.74 ± 2.89 39.3 ± 0.78  28.81 ± 3.01 39.76 ± 1.04 
Birthweight (g) 1238 ± 258.4  1434 ± 498.0  1185 ± 471.4 3466 ± 435.7  1207 ± 0.48 3543 ± 0.46 
Birthweight z-scoreb 0.03 ± 0.68  0.02 ± 0.67  -0.10 ± 0.84 0.33 ± 0.87c  -0.06 ± 0.87 0.49 ± 0.91c 
Weight/length (kg/m) 0.04 ± 0.01  0.05 ± 0.01  0.06 ± 0.01 0.07 ± 0.01  0.10 ± 0.01 0.09 ± 0.01 
BMI (kg/m2) 9.37 ± 1.09  11.36 ± 1.08  13.37 ± 1.37 13.71 ± 1.01  16.81 ± 1.86 15.68 ± 1.69 
PI (kg/m3) 23.37 ± 1.96  26.04 ± 2.55  28.55 ± 2.90 26.10 ± 1.98  27.80 ± 4.01 26.46 ± 2.24 
Sex (male) 30 (40.54%)  89 (50.86%)  62 (54.87%) 35 (50.00%)  59 (53.15%) 47 (49.47%) 
Race (white) 12 (16.22%)  64 (37.14%)  32 (28.32%) 57 (81.43%)  7 (6.31%) 78 (82.11%) 
          
Body Composition          
CGA (weeks) 32.27 ± 1.20  35.15 ± 0.80  38.85 ± 1.45 41.74 ± 0.79  57.04 ± 3.45 50.21 ± 4.07 
Body Mass (kg) 1.52 ± 0.32  2.17 ± 0.32  2.97 ± 0.54 3.80 ± 0.38  6.24 ± 1.03 5.58 ± 1.14 
Length (cm) 40.03 ± 2.08  43.67 ± 2.13  46.94 ± 2.96 52.59 ± 1.58  60.82 ± 4.25 59.27 ± 3.80 
Body fat (%)  8.03 ± 3.93  12.45 ± 4.71  18.23 ± 4.91 14.57 ± 3.90  22.87 ± 4.87 22.12 ± 6.78 
Fat mass (kg) 0.13 ± 0.09  0.28 ± 0.13  0.55 ± 0.20 0.56 ± 0.18  1.45 ± 0.46 1.29 ± 0.59 
Fat-free mass (kg) 1.39 ± 0.26  1.90 ± 0.26  2.42 ± 0.41 3.24 ± 0.30  4.77 ± 0.70 4.28 ± 0.64 
aContinuous variables expressed as mean ± SD or n (%)  
bFenton z-score; cWHO z-score 
BMI, body mass index; CGA, corrected gestational age; GA, gestational age at birth; PI, ponderal index 




Table 3.2: Pearson’s correlation coefficients for predictors and outcomes in 260 
preterm infants by corrected gestational age at measurement 
Predictor Fat mass  Body fat (%) Fat-free mass 
CGA Group 1 (n=74)    
Weight (kg) *0.753 *0.536 *0.972 
Length (cm) *0.580 *0.394 *0.913 
Weight/length (kg/m)  *0.774 *0.562 *0.954 
BMI (kg/m2) *0.782 *0.585 *0.888 
PI (kg/m3) *0.688 *0.541 *0.637 
CGA Group 2 (n=175)    
Weight (kg) *0.608 *0.355 *0.924 
Length (cm) *0.208 -0.029 *0.842 
Weight/length (kg/m)  *0.700 *0.478 *0.830 
BMI (kg/m2) *0.729 *0.585 *0.575 
PI (kg/m3) *0.602 *0.580  0.148 
CGA Group 3 (n=113)    
Weight (kg) *0.756 *0.402 *0.947 
Length (cm) *0.480  0.134 *0.872 
Weight/length (kg/m)  *0.812 *0.497 *0.877 
BMI (kg/m2) *0.776 *0.581 *0.618 
PI (kg/m3) *0.485 *0.504  0.090 
CGA Group 4 (n=111)    
Weight (kg) *0.759 *0.412 *0.902 
Length (cm) *0.538 *0.204 *0.812 
Weight/length (kg/m)  *0.723 *0.434 *0.781 
BMI (kg/m2) *0.470 *0.360 *0.362 
PI (kg/m3)  0.080  0.177 -0.157 
*indicates significance at p < .05 
BMI, body mass index; CGA, corrected gestational age; PI, ponderal index; RMSE, root mean 




















Table 3.3: R2 and root MSE for prediction of body composition by weight/length 
indices in preterm infants by corrected gestational age   
 Body fat (%)  Fat mass   Fat-free mass  
Predictor R2 RMSE  R2 RMSE  R2 RMSE 
CGA Group 1 (n=74)         
Weight (kg) 0.288 3.338  0.567 0.058  0.944 0.063 
Length (cm) 0.155 3.636  0.336 0.072  0.834 0.108 
Weight/length (kg/m)  0.316 3.271  0.599 0.056  0.911 0.079 
BMI (kg/m2) 0.342 3.209  0.612 0.055  0.788 0.123 
PI (kg/m3) 0.293 3.325  0.473 0.064  0.406 0.205 
CGA Group 2 (n=175)         
Weight (kg) 0.126 4.419  0.369 0.101  0.854 0.100 
Length (cm) 0.001 4.726  0.043 0.124  0.709 0.141 
Weight/length (kg/m)  0.229 4.151  0.489 0.090  0.689 0.146 
BMI (kg/m2) 0.346 3.824  0.534 0.086  0.327 0.214 
PI (kg/m3) 0.339 3.843  0.364 0.101  0.021 0.259 
CGA Group 3 (n=113)         
Weight (kg) 0.161 4.513  0.572 0.132  0.897 0.132 
Length (cm) 0.018 4.884  0.223 0.178  0.761 0.202 
Weight/length (kg/m)  0.248 4.275  0.656 0.118  0.769 0.198 
BMI (kg/m2) 0.337 4.012  0.598 0.128  0.381 0.325 
PI (kg/m3) 0.254 4.257  0.228 0.177  0.008 0.411 
CGA Group 4 (n=111)         
Weight (kg) 0.170 4.460  0.577 0.300  0.813 0.305 
Length (cm) 0.042 4.793  0.290 0.389  0.659 0.412 
Weight/length (kg/m)  0.189 4.410  0.522 0.319  0.610 0.441 
BMI (kg/m2) 0.129 4.569  0.221 0.407  0.131 0.658 
PI (kg/m3) 0.031 4.819  0.007 0.460  0.025 0.697 
BMI, body mass index; CGA, corrected gestational age; PI, ponderal index; RMSE, root mean 
























Figure 3.1 Scatterplot of the relationship between BMI and %BF                                 
in 74 preterm infants measured between 28-33 weeks corrected gestational age.   
 
 
Figure 3.2: Scatterplot of the relationship between BMI and %BF in 175 preterm 









Figure 3.3 Scatterplot of the relationship between BMI and %BF in 113 preterm 




Figure 3.4 Scatterplot of the relationship between WL and %BF in 111 preterm 









Table 3.4: Relationship between predictors and FMI and FFMI in preterm infants by 
CGA group 
 FMI  FFMI  
Predictor R2 RMSE  R2 RMSE 
CGA Group 1 (n=74)      
Weight/length (kg/m)  0.492 0.000034  0.804 0.000037 
BMI (kg/m2) 0.530 0.000032  0.830 0.000035 
PI (kg/m3) 0.456 0.000035  0.656 0.000049 
CGA Group 2 (n=175)      
Weight/length (kg/m)  0.365 0.000051  0.606 0.000048 
BMI (kg/m2) 0.511 0.000045  0.659 0.000045 
PI (kg/m3) 0.470 0.000047  0.442 0.000057 
CGA Group 3 (n=113)      
Weight/length (kg/m)  0.439 0.000062  0.567 0.000061 
BMI (kg/m2) 0.585 0.000053  0.663 0.000054 
PI (kg/m3) 0.430 0.000063  0.411 0.000071 
CGA Group 4 (n=111)      
Weight/length (kg/m)  0.373 0.000084  0.308 0.000096 
BMI (kg/m2) 0.366 0.000084  0.568 0.000076 
PI (kg/m3) 0.163 0.000097  0.479 0.000083 
CGA, corrected gestational age; FMI, fat mass index (FM/length2); FFMI, fat-free mass index 





























Table 3.5: Relationship between W/L indices and %BF by GA at birth and sex in 
260 preterm infants <32 weeks vs ≥ 32 weeks GA at birth 
 Body fat (%) 
Predictor Estimate ± SE 95% CL P-value AICC Df 
      
Weight (kg)  3.30 ± 0.29  2.74, 3.86 <.0001 2764.0 467 
   Intercept  2.32 ± 1.06  0.24, 4.40 0.0287  467 
   GA   6.58 ± 1.10  4.42, 8.74 <.0001  467 
   Sex -1.07 ± 0.83 -2.70, 0.56 0.1983  464 
   GA*Weight  -1.02 ± 0.30 -1.61, -0.43 0.0007  465 
   Sex*Weight   0.35 ± 0.21 -0.07, 0.76 0.1000  339 
      
Length (cm)  0.80 ± 0.07  0.65, 0.95 <.0001 2821.4 466 
   Intercept -26.4 ± 3.76 -33.7, -19.0 <.0001  467 
   GA   18.3 ± 3.81  10.8, 25.8 <.0001  467 
   Sex  -2.22 ± 2.47 -7.08, 2.65 0.3706  364 
   GA*Length -0.29 ± 0.08 -0.44, -0.14 0.0002  467 
   Sex*Length  0.05 ± 0.05 -0.05, 0.14 0.3731  345 
      
Weight/length (kg/m)   2.65 ± 0.21  2.24, 3.06 <.0001 2701.5 465 
   Intercept -3.59 ± 1.38 -6.31, -0.87 0.0098  467 
   GA   8.05 ± 1.44  5.23, 10.88 <.0001  467 
   Sex  -1.17 ± 1.04 -3.21, 0.87 0.2613  426 
   GA*Weight/length -0.81 ± 0.22 -1.24, -0.38 0.0002  467 
   sex*Weight/length  0.21 ± 0.15 -0.08, 0.51 0.1492  341 
      
BMI (kg/m2)  2.39 ± 0.18  2.04, 2.73 <.0001 2637.9 454 
   Intercept -16.7 ± 2.21 -21.0, -12.3 <.0001  460 
   GA  10.7 ± 2.31  6.15, 15.2 <.0001  464 
   Sex -0.89 ± 1.56 -3.96, 2.19 0.5706  384 
   GA*BMI -0.69 ± 0.18 -1.05, -0.32 0.0002  462 
   sex*BMI  0.09 ± 0.12 -0.14, 0.33 0.4227  348 
      
PI (kg/m3)  1.37 ± 0.25  0.88, 1.86 <.0001 2989.7 433 
   Intercept -21.5 ± 6.26 -33.8, -9.21 0.0006  438 
   GA  6.73 ± 6.50 -6.05, 19.5 0.3011  433 
   Sex  1.33 ± 4.21 -6.95, 9.61 0.7530  467 
   GA*PI -0.22 ± 0.26 -0.72, 0.28 0.3909  431 
   Sex*PI -0.06 ± 0.16 -0.37, 0.25 0.6897  467 
AIC, Akaike information criterion, corrected; BMI, body mass index; GA, gestational age at birth; 
PI, ponderal index 






Table 3.6: Relationship between W/L indices and %BF by gestational age and sex 
in term infants versus preterm infants at term-corrected age 
 Body fat (%)  
Predictor Estimate ± SE 95% CL P-value AICC Df 
      
Weight (kg)  4.48 ± 0.26  3.97, 5.00 <.0001 2223.6 170 
   Intercept -3.50 ± 1.33 -6.10, -0.88 0.0090  204 
  Term Status (TS)  16.4 ± 1.40  13.6, 19.1 <.0001  224 
   Sex  0.88 ± 1.27 -1.62, 3.37 0.4887  294 
   TS*weight  -2.97 ± 0.28  -3.52, -2.42 <.0001  187 
   Sex*weight   0.13 ± 0.25 -0.37, 0.63 0.6154  247 
      
Length (cm)  1.15 ± 0.08  1.00, 1.31 <.0001 2325.7 184 
   Intercept -46.7 ± 4.56 -55.7, -37.7 <.0001  185 
   TS  49.5 ± 4.66  40.3, 58.7 <.0001  190 
   Sex  2.88 ± 3.74 -4.48, 10.2 0.4413  275 
   TS*Length -0.83 ± 0.08 -1.00, -0.67 <.0001  189 
   Sex*Length -0.03 ± 0.07 -0.16, 0.11 0.6774  272 
      
Weight/length (kg/m)   3.69 ± 0.21  3.28, 4.10 <.0001 2199.6 175 
   Intercept -13.0 ± 1.79 -16.5, -9.45 <.0001  189 
   TS  22.0 ± 1.92  18.2, 25.8 <.0001  213 
   Sex  0.40 ± 1.74 -3.02, 3.83 0.8169  281 
   TS*weight/length -2.38 ± 0.22 -2.82, -1.94 <.0001  197 
   Sex*weight/length  0.13 ± 0.20 -0.27, 0.53 0.5314  259 
      
BMI (kg/m2)  3.29 ± 0.20  2.91, 3.68 <.0001 2207.4 231 
   Intercept -30.7 ± 2.94 -36.4, -24.9 <.0001  235 
   TS  30.3 ± 3.23  23.9, 36.6 <.0001  278 
   Sex  0.34 ± 2.99 -5.54, 6.23 0.9092  341 
   TS*BMI -1.95 ± 0.21 -2.37, -1.53  <.0001  273 
   Sex*BMI  0.07 ± 0.20 -0.32, 0.46 0.7358  334 
      
PI (kg/m3) 1.65 ± 0.22  1.22, 2.08 <.0001 2242.3 383 
   Intercept -24.9 ± 5.81  -36.4, -13.5 <.0001  383 
   TS  31.3 ± 6.19  19.2, 43.5 <.0001  383 
   Sex  7.38 ± 4.99 -2.43, 17.2 0.1400  383 
   TS*PI -1.16 ± 0.23 -1.61, -0.70 <.0001  383 
   Sex*PI -0.24 ± 0.18 -0.60, 0.11 0.1803  383 
AIC, Akaike information criterion, corrected; BMI, body mass index; PI, ponderal index; TS, term 






Weight for length indices consist of non-invasive anthropometric measures that are 
already obtained in the NICU on a routine basis. If reflective of adiposity, use of these 
indices would be a relatively simple process, potentially allowing clinicians to track the 
quality of weight gain throughout an infant’s NICU stay. Monitoring weight quality via 
body composition in tandem with nutrition intervention may improve the overall ability of 
clinicians to optimize nutrition, promote neurodevelopment, and reduce the risk of 
obesity and metabolic disease.  
While BMI was strongly correlated with FM and moderately correlated with %BF 
for all CGA groups except for group four, it was a poor predictor of %BF and FM for all 
CGA groups due to low R2 values and large prediction errors. Of the W/L indices 
examined, BMI was the best predictor of %BF until CGA 43-65 weeks, where W/L was 
the best predictor of %BF. W/L indices of BMI and W/L had only moderate ability to 
predict an infant’s whole body FM. These indices similarly predicted FM until preterm 
infants were of term-corrected age, when W/L (37-42 weeks CGA) or weight (43-63 
weeks CGA) became better predictors.  
 Some have argued that use of FFMI and FMI are more useful than FFM and FM 
for comparison of adiposity in individuals because they are normalized for body size. 
Most of our predictors (W/L, BMI, PI) were calculated using length in the denominator, 
so we examined their ability to predict two of our outcomes on the same general scale. 
FFMI and FMI are essentially length-normalized indices of BMI, so it was not surprising 
that BMI was the best predictor of both outcomes. However, because of its ability to 
predict both outcomes, an elevated BMI could represent either increased FM or FFM.  
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 Our results align with the results of our previous study and other similar studies, 
which found that BMI was a poor predictor for %BF and had large prediction 
errors.10,111,115 A study by Roy et al. found that high BMI z-scores in early infancy (for 
term infants) had a greater association with later childhood obesity than W/L z-scores, 
indicating that although BMI is not an adequate surrogate for adiposity, it may be worth 
monitoring in children younger than 2 years old.116 Furthermore, BMI measurements 
were more consistent than W/L measurements over time. In contrast, a study by Aris et 
al. did not find a difference between the ability of BMI and W/L to predict cardiometabolic 
outcomes in early adolescence, although adiposity was assessed using bioimpedance, 
which may have underestimated FM.117  
   In the clinical setting, W/L is used to assess the appropriateness of infant weight 
gain until age two, but BMI may be a better indication of adiposity until a preterm infant 
reaches 43 weeks corrected age. However, the WHO W/L growth charts do not account 
for infant age, which may be problematic for preterm infants, who have a greater amount 
of FM (and greater %BF) than their peers at term-corrected age but may be shorter in 
length. Unfortunately, prediction errors may prevent use of BMI to provide estimates of 
%BF at the individual level. Additionally, in infants and children, BMI can represent a 
large variation in %BF.118 
BMI was a strong predictor for FFM between 28-33 weeks CGA, but the effect 
diminished with increasing age as FM and %BF increased. Weight and length were 
consistently good predictors of FFM across all CGA groups, which is not surprising for 
the younger CGA groups given that the majority of an infant’s weight consists of FFM. 
The predictive ability of these indices decreased as preterm infants grew older, which is 
expected as their %BF increased.  
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 We found that GA at birth (< 32 weeks or > 32 weeks) was a significant predictor 
for %BF in models containing W/L indices, GA, and sex with significant interaction 
between GA and W/L indices (except for PI). This indicates that the predictive ability of 
W/L indices is affected by early versus late preterm status and should be considered as 
a covariate in future analyses. We also found a significant interaction between term 
status and W/L indices when comparing predictive ability in term infants versus preterm 
infants at term-corrected age. This indicates that the ability of W/L indices to predict 
%BF is different for term infants than in preterm infants at term-corrected age. 
 Our study was limited by the fact that a significant proportion of infants did not 
have race reported. Thus, we are unable to comment on the applicability of our results to 
other populations. Our study also contained twins and triplets whose measurements may 
have been correlated. We examined only single predictors in our study, but inclusion of 
additional covariates such as CGA and sex may have improved the predictive ability of 
our models.  
To our knowledge, this is the first study to examine the relationship between W/L 
indices and body composition outcomes in preterm infants ≥ one week through 63 
weeks CGA. We have confirmed that thus far, we do not have a way to measure 
adiposity in preterm infants, and weight and BMI are not adequate surrogates for 
adiposity. Our study results emphasize the importance of continued exploration of 
bedside body composition methods to help assess disease risk and improve 
neurodevelopmental outcomes in preterm infants.  
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CHAPTER 4: ULTRASOUND MEASUREMENTS OF MUSCLE AND ADIPOSE 
TISSUE THICKNESS ARE NOT SURROGATES FOR WHOLE BODY COMPOSITION 




















*Publication Citation (portions of results have been presented as an abstract):          
Nagel E, Hickey M, Ramel S, et al. Ultrasound measurements of adipose and muscle 
thickness are correlated with whole body fat and fat-free mass in premature infants. 




Background and Objectives: Premature infants are at risk for adverse metabolic and 
neurodevelopmental outcomes due to growth alterations in early infancy. Monitoring 
body composition by tracking gains in fat mass and fat-free mass may assist clinicians in 
preventing obesity and metabolic disease while promoting optimal growth and 
development. A prospective, observational study was conducted to determine the ability 
of ultrasound measurements of muscle and adipose tissue thickness to predict whole 
body composition, including fat-free mass, fat mass, and percent body fat.   
Methods: Sixty-eight (n=68) healthy premature infants (mean gestational age at birth = 
32 weeks) were recruited from the Neonatal Intensive Care Unit at the University of 
Minnesota. Anthropometric measurements, air displacement plethysmography, and 
ultrasound measurements of the biceps, abdomen, and quadriceps were conducted 
when infants were medically stable. Intra-rater reliability of ultrasound measurements 
was evaluated using percent coefficient of variation and intraclass correlation coefficient. 
The relationship between ultrasound measurements and body composition was 
assessed using Pearson’s correlation coefficient and linear regression analysis.  
Results: Ultrasound measurements of muscle and adipose tissue showed good to 
excellent intra-rater reliability (ICC = 0.87-0.98; %CV = 4.8-13.5%). Biceps (r = 0.56) and 
quadriceps muscle (r = 0.51) thickness were moderately but significantly correlated with 
fat-free mass (p <.0001). Adipose tissue thickness of the biceps (r = 0.43; r = 0.32), 
abdomen (r = 0.43; r = 0.34), and quadriceps (r = 0.40; r = 0.28) were weakly but 
significantly correlated with fat mass (p < .01) and percent body fat (p < .05). In stepwise 
linear regression analysis, biceps adipose and the sum of adipose thickness 
measurements were significant predictors of %BF, but prediction models had low R2 and 
high RMSE. US measurements of muscle thickness were not predictive of whole body 
FFM.   
Conclusions: Ultrasound measurements of biceps, abdomen, and quadriceps muscle 
and adipose tissue thickness are not adequate surrogates for whole body composition in 






Premature infants are at risk for obesity and metabolic disease because of altered 
growth, including increased adiposity, decreased fat-free mass (FFM) gains, and 
decreased linear growth for the first two years of life.3–6 Catch up growth or a rapid 
period of growth in early infancy may also increase their risk for later insulin resistance, 
obesity, and cardiovascular disease.22,101–103 Our previous research found that higher 
gains in fat mass (FM) from discharge until 4 months of age are positively associated 
with blood pressure at 4 years of age.9 Additionally, we discovered that FFM is a better 
predictor of neurodevelopmental outcomes than weight, and gains in FFM (but not FM) 
are related to improved neurodevelopmental outcomes.6,8,22,24 Little is known about the 
long-term consequences of growth alterations premature infants experience in the 
neonatal intensive care unit (NICU), but monitoring changes in body composition by 
tracking gains in FM and FFM may help assess their risk for later adverse metabolic and 
neurodevelopmental outcomes.  
Currently, body composition is not routinely monitored in the NICU. While 
magnetic resonance imaging (MRI),29 isotope dilution techniques, air displacement 
plethysmography (ADP), and dual energy x-ray absorptiometry (DXA) have been studied 
in premature infants, these methods are not feasible for routine use in the NICU because 
they require respiratory/medical stability, involve exposure to ionizing radiation, or are 
expensive.119,120 Bedside methods such as skinfold thickness and bioimpedance analysis 
have been proposed to assess body composition in premature infants but have not been 
validated and have limitations that prevent their routine use in this population. In 
adolescent and adult populations, ultrasound (US) measurements of muscle and 
adipose tissue thickness have been used to predict whole body composition.85,90,92 US is 
an ideal method for use in premature infants because it is portable, non-invasive, 
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involves no ionizing radiation, and is suitable for repeated measurements regardless of 
medical stability. US also has the potential for body composition assessment throughout 
the life cycle but has not been thoroughly examined in premature infants. In this study, 
we aimed to determine if US measurements of muscle and adipose tissue thickness are 
predictive of whole body composition (FFM, FM, percent body fat (%BF)) in premature 
infants.  
METHODS 
This study was approved by the University of Minnesota Institutional Review 
Board. Healthy premature infants were recruited from the University of Minnesota 
Masonic Children’s Hospital Neonatal Intensive Care Unit between November 2018 and 
May 2019. Study inclusion criteria were birth between 25 and 34 + 6 weeks gestational 
age (GA), medical and respiratory stability, and independence from central intravenous 
catheters at time of measurement. Parents of the infants provided informed consent. 
During the recruitment period, 221 eligible infants were admitted to the NICU. Of the 
infants not consented to the study, 64 declined, 70 were unable to be consented, 18 
transferred, and 1 died. Sixty-eight healthy premature infants were consented. Of these, 
one patient was transferred to an outside facility before measurements could be 
conducted. One infant had insufficient body fat for measurement via ADP, one infant 
was discharged before measurements were conducted, and two did not have complete 
ultrasound measurements available for analysis. Sixty-three (n=63) infants remained and 
were included in this study.   
The Pea Pod (Cosmed Ltd, Concord, California) was used to conduct ADP. The 
Pea Pod’s operating procedures have been described elsewhere.44–46,121 Briefly, each 
infant’s length was obtained to the nearest 0.1 cm using a recumbent length board. The 
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infant was then weighed on the Pea Pod’s electronic scale to the nearest 0.0001 kg 
followed by an approximately 2-minute body volume measurement in the device’s test 
chamber. The body volume measurement, the known density of fat (0.9007 g/mL), and 
Fomon’s34 or Butte’s35 age and sex specific densities for FFM were then used in the Pea 
Pod’s calculation of %BF. All measurements were taken by a consistent study team.  
US images of the biceps (brachii and brachialis), abdomen (rectus abdominus), 
and quadriceps (vastus intermedius and rectus femoris) and were taken in triplicate on 
the left side of the infant’s body using a portable B-mode ultrasound device (NextGen 
LOGIQ e R7, GE Medical Systems, Chicago, IL) and high-resolution linear array 
transducer (LS 10-22-RS, GE Medical System, Chicago, IL). Ultrasound methodology for 
adults has been previously published but to our knowledge, no protocol for infants 
currently exists.81–83,122 Therefore, the following methodology was adapted from adult 
guidelines. All measurements were taken by one trained operator while the infant was in 
a supine position. Measurements were conducted using zero compression by resting the 
transducer on a thick layer of US gel. Ultrasound measurements of the biceps were 
taken with the infant’s palm facing upward and arm positioned slightly away from the 
body. Point of measurement was determined by visualizing the halfway point between 
the acromion and antecubital crease. US measurements of the abdomen were taken 
midway between the costal margin and anterior superior iliac crest, immediately to the 
left of umbilicus. Measurements were taken during the expiration portion of the 
respiratory cycle to prevent artificial inflation of abdominal adipose thickness. US 
measurement of the quadriceps were taken with the infant’s knee extended and 
quadriceps muscle in a relaxed state. To obtain measurements, the transducer was 
placed approximately halfway between the anterior superior iliac spine and the superior 
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patellar border. After each US image was obtained, adipose tissue and muscle thickness 
were measured using electronic calipers (Figure 1). The mean of three measurements 
was used for calculations. If three measurements were unable to be obtained, the mean 
of two measurements or one measurement was used instead.  
 







a) Biceps         b) Abdomen   c) Quadriceps 
 




SAS 9.4 (SAS Institute, Cary, North Carolina) was used to perform statistical analyses. 
Intra-rater reliability was assessed by percent coefficient of variation (%CV) and 
intraclass correlation coefficient (ICC).123 The relationship between US measurements 
and whole body composition was assessed using Pearson’s Correlation Coefficient. To 
determine the ability of individual US measurements to predict FFM, FM, or %BF, simple 
linear regression analysis was first employed. Stepwise linear regression analysis was 
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then used to assess the ability of individual US measurements to predict outcomes of 
FM, FFM, and %BF in the presence of other predictors, including gestational age at 
birth, corrected age at measurement, weight, and length, and sex. The sum of US 
measurements was also considered as a predictor of outcomes in a separate analysis. 
The criterion for variable entry into a given model (significance level for entry, SLE) was 
set at p ≤ 0.15, and the criterion for a variable to stay in the model (significance level for 
staying, SLS) was set at 0.05. The best model for a given outcome was that which 
explained the highest proportion of variance (R2) with the lowest root mean square error 
(RMSE).  
Because the study population included eleven sets of twins and three sets of 
triplets, a sensitivity analysis was performed. One member of each siblingship was 
selected for inclusion in the analysis, and the models were re-run and assessed for 
differences from the results of the original analysis.  
RESULTS 
Participant Characteristics 
Characteristics of infants who participated in the study are described in Table 4.1. Of the 
68 infants enrolled in the study, 63 had ultrasound measurements at all three sites and 
body composition values generated via ADP. The majority of infants were female (56%) 
and white (76%). Mean gestational age at birth was 32 weeks (± 2.24 weeks, SD). Mean 
weight at time of measurement was 2165 grams (± 360.7 grams, SD), while mean length 
was 44.1 cm (± 2.27 cm, SD).  Mean corrected age at measurement was 35.1 weeks 




Intra-rater reliability of ultrasound measurements is shown in Table 4.2. Ultrasound 
measurements at all sites had %CV between 4.8-13.5%, with the highest %CV reported 
for biceps adipose thickness. ICC for all ultrasound measurements ranged from 0.874-
0.975.  
Table 4.1: Descriptive characteristics of preterm infants (n=63)  
Variable Dataa 
  
Gestational age at birth (weeks) 32.0 (2.24) 
Sex (male) 28 (44%) 
Race  
    White 48 (76.2%) 
    Black   6 (9.52%) 
    Other   9 (14.3%) 
Corrected age at measurement (weeks) 35.1 (1.19) 
Weight (grams) 2165 (360.7) 
Length (cm) 44.1 (2.27) 
FFM (grams) 1973.9 (325.3) 
FM (grams) 191.5 (94.5) 
%BF  8.72 (3.88) 
Biceps adipose thickness (mm) 1.85 (0.49) 
Biceps muscle thickness (mm) 7.90 (1.25) 
Abdominal adipose thickness (mm) 2.21 (0.61) 
Abdominal muscle thickness (mm) 2.46 (0.61) 
Quadriceps adipose thickness (mm) 2.51 (0.80) 
Quadriceps muscle thickness (mm) 11.3 (2.04) 
  
aContinuous variables expressed as mean (standard deviation) and categorical variables 
as n (percentage)  
 
Table 4.2: Intra-rater reliability of ultrasound measurements  
Measurement Site %CVa  ICCb 
Biceps adipose thickness  13.5 0.873 
Biceps muscle thickness  3.86 0.975 
Abdominal adipose thickness  10.6 0.930 
Abdominal muscle thickness  8.83 0.949 
Quadriceps adipose thickness  4.8 0.963 
Quadriceps muscle thickness  9.2 0.968 
aPercent coefficient of variation  




US measurements of muscle thickness and whole body FFM 
Both biceps muscle (r=0.56) and quadriceps muscle (r = 0.51) were moderately but 
significantly correlated with FFM (p < .05) (Table 4.3). Table 4.6 shows the relationship 
between individual US measurements of muscle thickness and whole body FFM. All 
models had low R2 values. Table 4.7 shows the results of stepwise regression analysis. 
The best linear regression model had an adjusted R2 = 0.94 and included weight, length, 
and gestational age at birth. None of the US measurements of muscle were selected for 
model inclusion because they did not meet SLE requirements. Similarly, in a separate 
analysis, the sum of all muscle thickness measurements (USM) was not selected in 
stepwise regression analysis and was therefore excluded from the best-fitting model.  
Table 4.3: Pearson’s correlation coefficients for US measurements of muscle 
thickness and whole body FFM 
Measurement site (mm) FFM  
Biceps muscle  *0.56 
Abdominal muscle    0.23 
Quadriceps muscle  *0.51 
*indicates significance at p < .0001 
 
 
US measurements of adipose tissue thickness and whole body FM and %BF 
Biceps adipose tissue (r =0.43), abdominal adipose tissue (r =0.43), and quadriceps 
adipose tissue (r =0.40), were moderately but significantly correlated with whole body 
FM (Table 4.4). All three adipose sites were also weakly but significantly correlated with 
%BF. Table 4.5 shows models generated during simple linear regression of individual 
US measurements of adipose thickness on FM and %BF. All models had low R2, and the 
models for %BF had greater RMSE values than the models for FM. In stepwise linear 
regression analysis, the final regression model for FM had a low R2 value (0.34) and 
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included weight, length, and gestational age at birth (Table 4.8). In a separate 
regression analysis, the sum of all adipose thickness measurements (USA) was not 
selected in the final model, which included weight, length, and gestational age at birth. 
For %BF, biceps adipose tissue thickness and gestational age were included in the final 
model, which had a low R2 (0.17) and high prediction error (RMSE = 3.54) (Table 4.9). 
When the sum of all US adipose thickness measurements (USA) was tested as a 
predictor in a separate analysis, the resulting model included USA and gestational age 
at birth but had low R2 (0.16) and high RMSE (3.57).  
Table 4.4: Pearson’s correlation coefficients for US  
measurements of adipose tissue and whole body FM and %BF 
Measurement site (mm) FM %BF 
Biceps adipose  *0.43 *0.32 
Abdominal adipose  *0.43 *0.34 
Quadriceps adipose  *0.40 *0.28 
 
*indicates significance at p < .05 
 
Sensitivity Analysis 
Results of the sensitivity analysis showed slight differences in models for prediction of 
FM and %BF from USA (Supplemental Table 4.1). When only one member of each 
siblingship was selected for inclusion in data analysis, USA and CGA were included in 
the final model for prediction of FM from the sum of US adipose thickness 
measurements USA and length were included in the final model predicting %BF from 






Body composition, while linked to neurodevelopmental and metabolic outcomes in 
preterm infants, is not routinely measured in the NICU due to limitations of currently 
available tools. Ultrasound, a non-invasive, portable device is highly desirable for 
measurement of body composition in a medically fragile population. In this study, we 
have shown that bedside ultrasound can detect and measure muscle and adipose tissue 
thickness in premature infants with good to excellent reliability (ICC). Variability relative 
to the mean of measurements (%CV) was highest for biceps adipose tissue thickness 
(13.5%), also the smallest of all muscle and adipose tissue thickness measurements. 
Our results are in contrast to those of McLeod and colleagues,95 who found that %CV for 
US measurements in preterm infants was highest for thigh adipose tissue and lowest for 
midarm adipose tissue and mid-arm muscle tissue. This may be because their study 
population was slightly younger (mean gestational age of 27 weeks), and infants were 
older when measurements were taken (mean corrected age at measurement of 40 
weeks). This likely resulted in larger mean measurements of muscle and adipose tissue 
at each site. While McLeod measured 6 different sites (abdomen, subscapular, anterior 
and posterior arm, mid-arm, posterior and anterior thigh, and mid-thigh), ultrasound 
measurements were not compared with whole body composition. The only other study 
examining ultrasound in premature infants did not report reliability.93  
 We found that ultrasound measurements of biceps and quadriceps muscle 
thickness were moderately and significantly correlated with whole body FFM but were 
not significantly predictive when covariates of weight, length, gestational age at birth, 
and corrected age at measurement were included. A preterm infant’s weight is 
comprised predominantly of FFM and not surprisingly had the strongest effect on whole 
body FFM.10 Gestational age was included in the model and has a strong association 
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with FFM; infants born at an earlier gestational age have less absolute FFM.124 The sum 
of all muscle thickness measurements was not substantial enough to offset the effect of 
weight on FFM, likely explaining its exclusion from the best-fitting model.  
 Measurements of adipose tissue at all three sites were moderately and 
significantly correlated with whole body FM and weakly correlated with %BF, indicating 
the possibility that adipose thickness may be predictive of these outcomes. When 
competing against other, more easily measured anthropometric measures of body 
composition like weight and length, no US measurement of adipose thickness was 
retained in the final model, indicating none were predictive of whole body FM. However, 
biceps adipose thickness (BA) was selected in the regression model for %BF. 
Nonetheless, the low R2 and moderately high RMSE of the model limits confidence in 
the predictive ability of these measures. Similarly, the sum of adipose tissue thickness 
(USA) at all three sites was selected for the model for %BF but had low R2, again 
indicating low predictive ability.  
 Although the final models for prediction of FM and %BF from USA were slightly 
different upon inclusion of only one member of each set of twin and triplets in the data 
set, both models still had low variance explained and similar prediction error. Since no 
significant model improvement was seen with the inclusion of all members of each 
siblingship, the final data set contained no exclusions. 
Our ultrasound sites were selected based on adolescent and adult studies which 
found that muscle and adipose tissue thickness of the abdomen and quadriceps were 
representative of whole body composition.83,90 We also selected sites that would be 
simple to measure on a premature infant in the supine position. Our results are similar to 
those of Ahmad and colleagues, who found that the cross-sectional area of calf muscle 
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(r = 0.63) and adipose tissue (r = 0.67) but not thickness were significantly correlated 
with whole body composition.125  
 While other studies have found that FM differs based upon an infant’s sex, we 
did not note any differences in body composition for males in comparison to females, 
likely because the mean corrected age of the infants in our study was 35 weeks, and 
sex-specific differences may not be noted until later in life.126  
Our study was limited by the number of infants admitted to our NICU during the 
recruitment period, and our results may not be not representative of more diverse 
populations. Our study patients included twelve sets of twins and three sets of triplets, 
but we did not adjust for correlation of data due to lack of significant differences in our 
sensitivity analysis. We limited the number of ultrasound sites to three that were practical 
to obtain while the infant was in a supine position, but it is possible that inclusion of 
posterior region sites would have led to better-fitting models and should be considered in 
future studies. Furthermore, inclusion of measures of cross-sectional area may be more 
representative of whole body composition and should be explored. 
While we examined intra-rater reliability of ultrasound measurements, we did not 
assess inter-rater reliability due to time constraints. Infants were measured between 
feeding and care times and needed to be transported to a research room for US and 
ADP measurements. Because of the need for transport, nursing staff preferred that 
measurements occur immediately before feedings to prevent emesis and loss of 
nutrition. Consequently, infants became fussy when measured for a prolonged period of 
time, which would most likely affect additional ultrasound measurements taken during a 
study session. In the future, inter-rater studies would strengthen the reliability of 
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ultrasound measurements and would help facilitate the development of a consensus 
protocol for the use of US as a bedside assessment tool in this population.   
To our knowledge, our study is the first to correlate ultrasound measurements at 
multiple sites with whole body composition in premature infants. While measures of 
muscle and adipose thickness at the selected sites were not adequate proxies for whole 
body FFM, FM, or %BF, we were able to successfully modify adolescent and adult US 
protocols for use in premature infants, paving the way for future studies which may 
explore additional measures.  
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Table 4.5: Association of individual US measurements of adipose tissue thickness with FM and %BF in 63 preterm infants 
measured at mean corrected age of 35 weeks  
Variable P-value Regression equation for FM   Model 
Adj.R2 
Model RMSE (kg) 
     
Biceps (BA) 0.0004 0.08*BA+0.04 
 
0.18 0.09 
Abdomen (AA) 0.0004 0.07*AA+0.04 
 
0.17 0.09 
Quadriceps (QA) 0.0012 0.05*QA+0.07 
 
0.34 0.08 
 P-value Regression equation for %BF Model 
Adj.R2 
Model RMSE (kg) 
Biceps (BA) 0.0101 2.55*BA+4.0 
 
0.09 3.70 
Abdomen (AA) 0.0064 2.15*AA+3.96 
 
0.10 3.68 
Quadriceps (QA) 0.0250 1.37*QA+5.27 
 
0.06 3.75 









Table 4.6: Association of individual US measurements of muscle thickness with FFM in 63 preterm infants measured at 
mean corrected age of 35 weeks  
 
Variable P-value Regression equation for FFM   Model Adj.R2 Model RMSE (kg) 
     
Biceps (BM) <.0001 0.15*BM+0.82 0.31 0.27 
Abdomen (AM) 0.0584 0.12*AM+1.67 0.03 0.32 
Quadriceps (QM) <.0001 0.08*QM+1.06 0.25 0.28 















Table 4.7: Stepwise regression analysis for prediction of FFM from US measurements of muscle thickness and USM and 
weight, length, and GA in 63 preterm infants at mean corrected age of 35 weeks 
Step and variable Regression equation for FFM  Model Adj.R2 Model RMSE (kg) 
    
1. Weight 0.87*weight+0.08 0.93 0.08 
2. Length  0.73*weight+0.03*length-0.77 0.94 0.08 
3. GA 0.78*weight+0.02*length+0.01*GA-0.74 0.94 0.08 
Step and variable Regression equation for FFM   Model Adj.R2 Model RMSE (kg) 
1. Weight 
  
0.87*weight+0.08 0.93 0.08 
2. Length 0.73*weight+0.03*length-0.77 0.94 0.08 
3. GA 0.78*weight+0.02*length+0.01*GA-0.74 0.94 0.08 












Table 4.8: Stepwise regression analysis for prediction of FM from US measurements of adipose tissue thickness and USM, 
weight, length, and GA in 63 preterm infants at mean corrected age of 35 weeks  
Step and variable Regression equation for FM   Model Adj.R2 Model RMSE (kg) 
    
1. Weight 
 
0.13*weight-0.08 0.22 0.08 
2. Length 
  
0.27*weight-0.03*length+0.77 0.33 0.08 
3. GA  0.22*weight-0.02*length-0.01*GA+0.74 0.34 0.08 
Step and variable Regression equation for FM   Model Adj.R2 Model RMSE (kg) 
1. USA 
 
0.03*USA+0.01 0.22 0.08 
2. Weight 
  
0.02*USA+0.08*weight-0.09 0.27 0.08 
3. Length 0.01*USA+0.22*weight-0.02*length+0.65 0.33 0.08 
4. USA removed 0.27*weight-0.03*length+0.77 0.33 0.08 
5. GA  0.22*weight-0.02*length-0.01*GA+0.74 0.34 0.08 









Table 4.9: Stepwise regression analysis for prediction of %BF from US measurements of adipose tissue thickness and USA 
and GA in 63 preterm infants at mean corrected age of 35 weeks 
Step and variable Regression equation for %BF Model Adj.R2 Model RMSE (%BF) 
    
1. GA 
  
-0.62*GA+28.7 0.12 3.65 
3. Biceps (BA) -0.54*GA+2.07*BA +22.0 0.17 3.54 
Step and variable Regression equation for %BF Model Adj.R2 Model RMSE (%BF) 
1. USA 0.86*USA+3.05 0.12 3.64 
2. GA 0.62*USA-0.44*GA+18.8 0.16 3.56 



















Supplemental Table 4.1: Sensitivity Analysis: stepwise regression analysis for prediction of FM and %BF from the sum of 
US measurements of adipose tissue thickness, CGA, and length in 63 preterm infants at mean corrected age of 35 weeks 
Step and variable Regression equation for FM   Model Adj.R2 Model RMSE (%BF) 
    
1. USA 
 
0.03*USA+0.01 0.21 0.08 
2. CGA 
  
0.02*USA+0.02*CGA-0.65 0.25 0.08 
Step and variable Regression equation for %BF Model Adj.R2 Model RMSE (%BF) 
1. USA 0.74*USA+3.65 0.09 3.62 
2. Length 1.0*USA-0.47*length+22.9   
FM, fat mass; GA, gestational age at birth; RMSE, root mean square error; US, ultrasound; USA, sum of ultrasound measuremen
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Preterm infants experience altered growth patterns that may have later adverse 
effects on metabolic and neurodevelopmental health. Monitoring weight gain quality in 
response to nutritional provision as preterm infants grow may help clinicians decrease 
the risk for the development of obesity and other metabolic diseases while promoting 
optimal neurodevelopmental health.  
Some researchers have proposed the use of weight for length indices to monitor 
growth, but an evaluation of these indices (W/L, BMI, PI) reveals that none is an 
adequate surrogate for adiposity in preterm infants from 30-63 weeks corrected age. 
Thus, a bedside method for assessing body composition in preterm infants is highly 
desirable and requires further exploration.   
The primary purpose of this dissertation was to explore body composition 
methods in preterm infants, specifically ultrasound, a noninvasive bedside method which 
is relatively simple to conduct and does not require medical stability of the infant. When 
comparing ultrasound measures of biceps, abdomen, and quadriceps adipose and 
muscle thickness with whole body composition (FM, FFM, %BF) via ADP, we found that 
US measurements were not able to provide precise predictions of body composition due 
to low variation explained and/or high prediction error of resulting models. Inclusion of 
additional measurement sites or exploration of additional measures such as cross-
sectional area may improve the predictive ability of ultrasound measures.  
This dissertation work adds to previous research that found that weight for length 
indices were not predictive of adiposity in preterm infants within 72 hours after birth. This 
work demonstrates that weight for length indices cannot be used as proxies for adiposity 
in preterm infants ≥ 7 days after birth through 63 weeks corrected gestational age. 
However, it may be useful to monitor BMI, which is not currently tracked in infants or 
children less than 2 years old, as it was more predictive of FM and %BF than weight for 
length from 30-42 weeks corrected age.  
While ultrasound measurements at the biceps, abdomen, and quadriceps were 
not adequate surrogates for whole body composition in preterm infants, we have shown 
that measurement protocol can be successfully adapted from adult and adolescent 
protocols. Additionally, there may be some prognostic value in individual ultrasound 
measurements, namely whether they influence factors related to NICU discharge, such 
as time to full oral feeds. Continued exploration of bedside methods for assessment of 
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neonatal body composition, including the pursuit of alternate ultrasound measurement 
sites, is warranted in order to find a suitable method for tracking weight quality in 
response to nutritional provision.  
FUTURE DIRECTIONS  
This dissertation work provides a foundation for future studies that further explore the 
use of ultrasound measurements for prediction of whole body composition and clinical 
outcomes. The following sections contain a brief glimpse of some of the work to be 
conducted.  
Reliability of ultrasound measurements and longitudinal measurements 
While this dissertation explored intra-rater reliability via ICC and CV%, inter-rater 
reliability was not assessed due to logical constraints, including limited tie for 
measurements with the infants. To strengthen the results of future studies and confirm 
the appropriateness of our protocol, inter-rater studies should be conducted. 
Furthermore, if the goal is to find a bedside tool for routine assessment of body 
composition, the feasibility of longitudinal measurements should be investigated.  
Ability of ultrasound measurements of muscle thickness to predict neurodevelopmental 
outcomes 
Previous research has shown that gains in FFM (but not FM) are associated with 
improved neurodevelopmental outcomes in preterm infants at 1 year corrected age.8 
Whether changes in muscle tissue thickness, a more specific component of FFM, are 
also associated with improved neurodevelopmental outcomes is unknown. Ultrasound 
measurements should be taken longitudinally in the NICU with at least one timepoint on 
an outpatient basis after the infant reaches term-corrected age to assess this 
relationship. If proven to be predictive of neurodevelopmental outcomes, changes in 
measurements of muscle thickness could be tracked in response to nutritional 
intervention. This may ultimately help clinicians to improve neurodevelopmental 
outcomes for preterm infants.  
Ability of ultrasound measurements to predict metabolic outcomes and corrected age at 
discharge from the NICU 
A preterm infant’s discharge from the NICU is dependent on a myriad of factors such as 
respiratory stability, adequate growth, and the ability to consume oral feeds. We 
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conducted a secondary analysis of ultrasound measurements of muscle and adipose 
tissue thickness to predict systolic and diastolic blood pressure at discharge and 
corrected age at discharge.  
Data from forty-six preterm infants originally recruited from the University of 
Minnesota NICU for a study on ultrasound measurements and whole body composition 
was used for this analysis. Ultrasound measurements of the biceps, abdomen, and 
quadriceps were taken when infants were medically stable. Stepwise linear regression 
analysis was used to determine the ability of ultrasound measurements to predict clinical 
outcomes with covariates of gestational age at birth, weight, length, and corrected age at 
measurement. We also evaluated the relationship between the sum of ultrasound 
measurements and outcomes. The best model for a given outcome was that with had 
the highest R2 and lowest root mean square error (RMSE).  
Preliminary Data  
In linear regression analysis, biceps adipose thickness was a significant predictor 
of diastolic blood pressure (p=0.0386) but the final prediction model had low R2 (0.07) 
and high error (RMSE = 8.59). Adipose tissue thickness was not predictive of SBP.  
In linear regression analysis, abdominal muscle was significantly predictive of 
corrected age at discharge (p=0.0096) with R2=0.30. For every 1 mm increase in 
abdominal muscle, corrected age at discharge decreased by 0.89 weeks. In a separate 
analysis, the sum of ultrasound measurements of muscle thickness was also a 
significant predictor of corrected age at discharge (p=0.0079) with R2=0.26. For every 1 
mm increase in the sum of muscle thickness measurements, corrected age at discharge 
decreased by 0.23 weeks. These results are shown in Table 5.1. Adipose tissue was not 
significantly predictive of corrected age at discharge (p=0.1124), but biceps adipose was 
included in the final prediction model (Table 5.2). 
Should ultrasound measurements of adipose tissue thickness prove to be 
predictive of metabolic outcomes, they may be a useful in monitoring disease risk in 
preterm infants. While abdominal muscle and the sum of ultrasound muscle 
measurements were significantly predictive of corrected age at discharge and were 
included in final regression models, low R2 and moderate RMSE limit their predictive 
ability. Evaluation of additional US sites is warranted to determine if they can yield 
increased R2 and decreased RMSE. Should the ability of ultrasound measurements of 
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muscle thickness to predict corrected gestational age at discharge improve, ultrasound 
may be a useful tool for prediction of discharge from the NICU.  
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Table 5.1: Stepwise regression analysis for prediction of corrected age at discharge from US measurements of muscle 
thickness and USM, GA, weight, and length in 47 preterm infants at mean corrected age of 35 weeks   
 
Predictor Estimate ± SE P-value Model Adj.R2 Model RMSE 
   0.30 1.41 
GA -0.49 ± 0.12 0.0317   
CGA 0.95 ± 0.26 0.0326   
AM -0.89 ± 0.34 0.0096   
Weight -1.72 ± 0.90 0.0618   
Predictor Estimate ± SE P-value Model Adj.R2 Model RMSE 
   0.26 1.45 
GA -0.23 ± 0.11 0.0317   
CGA 0.67 ± 0.20 0.0326   
USM -0.23 ± 0.08 0.0079   
AM, abdominal muscle thickness; CGA, corrected gestational age at measurement; GA, gestational age at birth; RMSE, 









Table 5.2: Stepwise regression analysis for prediction of corrected age at discharge from US measurements of adipose 
thickness and GA, CGA, and weight in 47 preterm infants at mean corrected age of 35 weeks  
Predictor Estimate ± SE P-value Model Adj.R2 Model RMSE 
   0.24 1.47 
GA -0.36 ± 0.12 0.317   
CGA  0.85 ± 0.27 0.0326   
Weight -2.61 ± 1.02 0.0475   
BA 0.86 ± 0.53 0.1124   
BA, biceps adipose thickness; CGA, corrected gestational age at measurement; GA, gestational age at birth; RMSE, root 
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